Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-01-02
2007-01-02
Dentz, Bernard (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
10601314
ABSTRACT:
The present invention discloses methods of making a mixture of theaflavin, theaflavin-3-gallate, theaflavin-3′-gallate and theaflavin 3,3′-digallate, pharmaceutical compositions of the above mixture of theaflavins, diet supplement compositions of the above mixture of theaflavins and methods for using the above mixtures of theaflavin and pharmaceutical compositions thereof to treat or prevent various diseases. The present invention also discloses methods of making theaflavin, theaflavin-3-gallate, theaflavin-3′-gallate and theaflavin 3,3′-digallate, each as a separate compound, pharmaceutical compositions of the above compounds, diet supplement compositions of the above compounds and methods for using the above compounds to treat or prevent various diseases.
REFERENCES:
patent: 3228789 (1966-01-01), Glassman
patent: 3845770 (1974-11-01), Theeuwes et al.
patent: 3916899 (1975-11-01), Theeuwes et al.
patent: 4708834 (1987-11-01), Cohen et al.
patent: 4840966 (1989-06-01), Hara et al.
patent: 4935243 (1990-06-01), Borkan et al.
patent: 5318986 (1994-06-01), Hara et al.
patent: 5698155 (1997-12-01), Grosswald et al.
patent: 5879730 (1999-03-01), Bouwens et al.
patent: 6602527 (2003-08-01), Slaga et al.
patent: 2004/0097432 (2004-05-01), Roh-Schmidt et al.
patent: 19627344 (1999-03-01), None
patent: WO 01/93886 (2001-12-01), None
Abe et al, Japanese Journal of Food Chemistry, vol. 7(1), p. 47-50 (2000).
Vinson et al, FEBS Letters, 443,p. 44-46 (1998).
Ishikawa et al, Am. J. Clin. Nutr., 66, p. 261-266 (1997).
A. Finger, “in-vitro studies on the effect of polyphenol oxidase and peroxidase on the formation of polyphenolic black tea constituents”, J. Sci Food Agric, vol. 66, No. 3, 1994, pp. 293-305, XP002312128.
Patent Abstracts of Japan, 11032725, Mitsui Norin KK, Feb. 9, 1999.
Patent Abstracts of Japan, 6256180, Taiyo Kagaku Co Ltd, Sep. 13, 1994.
Chemical Abstracts, vol. 120, No. 63, 1994, abstract No.: 144138v,p. 691 col. 1, XP002312132.
Chemical Abstracts, vol. 127, No. 26, 1997, abstract No. 355154e, Meng. ME1: “influence of theaflavin on blood lipid . . . ”, p. 25 col. 2, XP002312133.
Chemical Abstracts, vol. 127, No. 14, 1997, abstract No. 19OO4Oz, Ishikawa, T. “effect of tea flavonoid supplementation . . . ”, p. 577, XP002312134.
Jee Y. Chung: “mechanisms of inhibition of the ras-MAP kinase . . . ”, FASEB Journal, vol. 15, No. 11, Sep. 2001 pp. 2022-2024, XP002312129.
Hashimoto, F. “evaluation of tea polyphenols as anti-HIV agents”, Bioorganic and Medicinal Chemistry Letters, vol. 6, No. 6, 1996, pp. 695-700, XP004135008.
H. Yoshida et al., “inhibitory effect of tea flavonoids on the ability of cells to oxidize 1 d 1”, Biochemical Pharmacology, vol. 58, No. 11, 1999, pp. 1695-1703, XP002312131.
Alderman D. A., “A Review of Cellulose Ethers in Hydrophilic Matrices for Oral Controlled-Release Dosage Forms,”Int. J. Pharm. Tech. Prod. Mfr. 5(3):1-9, 1984.
Bamba et al., “Release mechanisms in gelforming sustained release preparations,”Int. J. Pharm. 2:307, 1979.
Berge et al.,J. Pharm. Sci. 66:1-19, 1977.
Leung et al., “Theaflavins in Black Tea and Catechins in Green Tea Are Equally Effective Antioxidants,”J. Nutr. 131(9):2248-2251, 2001.
Sarkar et al.,Biochem. Biophys. Res. Commun. 284(1):173-178, 2001.
Verma et al.,Drug Dev. Ind. Pharm. 26:695-708, 2000.
Yoshino et al.,Biol. Pharm. Bull. 17(1):146-149, 1994.
“Black and Green Tea: How do they differ?”, Tea Health Facts, pp. 1-4, Sep. 3, 2002, http://www.teahealth.co.uk/th/facts/1.htm.
“Camellia sinensis (Tea)”, Biodiversity explorer, pp. 1-6, Sep. 5, 2002, http://www.museums.org.za/bio/plants/theaceae/camellia—sinesis.htm.
“Tea Polyphenols, water soluble, lipid soluble”, , Wuzhou International Co., Ltd., one-page, Sep. 5, 2002, http://www.chinax.com/pages/wuzhou/tea%20polyphenols.htm.
“Herbs—Green Tea (Camellia sinensis)”, Golden Temple Ingredients-Herbs-Green Tea (Camellia sinensis), pp. 1-3, Sep. 5, 2002, http://www.goldentemple.com/Clients/KIIT/GT/Ingredients.nsf/Ingredients/Green+Tea+(Camellia . . .
Eadington Mona, “Tea Polyphenolsl and Cancer Prevention”, Eadington/SJBR/2000, pp. 1-5, Sep. 5, 2002, http://wwwchem.csustan.edu/chem4400/SJBR/00eading.htm.
Goodsall, Chris et al., “The mechanism of theaflavin oxidation during black tea manufacture”, 2ndInternational Electronic Conference on Synthetic Organic Chemistry (ECSOC-2), http://www/mdpi.org/ecsoc/, Sep. 1-30, 1998, pp. 1-3, http://ecsoc2.hcc.ru/DP—TOP2/dp119/dp119.htm.
Yang, Chung S. et al., “The Chemistry of Tea”, p. 1-2, Sep. 5, 2002, http://www.teatalk.com/science/chemistry.htm.
The American Journal of Clinical Nutrition, Aug. 1997, vol. 66, No. 2, 11-pages.
Chen Hu
Zhao Jian
Zhou Rui
Cooley & Godward LLP
Dentz Bernard
Nashai Biotech, LLC
LandOfFree
Methods of making and using theaflavin,... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of making and using theaflavin,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of making and using theaflavin,... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3794088